SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL OMB Number: 3235-0104 Estimated average burden hours per response: 0.5

1. Name and Address of Reporting Person* Tarallo Francis J (Last) (First) (Middle) 5203 BRISTOL INDUSTRIAL WAY (Street) BUFORD GA 30518 (City) (State) (Zip)	2. Date of Event Requiring Statement (Month/Day/Year) 08/16/2005	3. Issuer Name and Ticker or Trading Symbol THERAGENICS CORP [ TGX ]
		4. Relationship of Reporting Person(s) to Issuer (Check all applicable) Director 10% Owner X Officer (give title below) Other (specify below) CFO & Treasurer	5. If Amendment, Date of Original Filed (Month/Day/Year)
			6. Individual or Joint/Group Filing (Check Applicable Line) X Form filed by One Reporting Person Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Theragenics Corporation Common Stock	4,935(1)	D
Theragenics Corporation Common Stock	10,000(3)	D
Theragenics Corporation Common Stock	3,000(2)	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Employee stock option (right to buy)	(4)	12/19/2009	Theragenics Corporation Common Stock	15,000	$8.875	D
Employee stock option (right to buy)	(5)	01/03/2011	Theragenics Corporation Common Stock	10,000	$5.375	D
Employee stock option (right to buy)	(6)	12/20/2012	Theragenics Corporation Common Stock	10,000	$4.28	D
Employee stock option (right to buy)	(7)	01/14/2015	Theragenics Corporation Common Stock	3,200	$3.95	D

Explanation of Responses:

1. Includes 1,375 shares in ESPP and 2,960 shares in 401(k) from Employer match in common stock valued on August 16, 2005.

2. Represents time-based vesting component of a performance restricted stock right. The performance restricted stock right provides for the issuance of 3,000 shares with time-based vesting and up to an additional 17,000 shares subject to performance-based vesting criteria (7,000 shares at target performance, 17,000 shares maximum achievable). The performance-based component of the right is not reportable under Section 16.

3. Restricted stock grant vesting 100% 12/31/2006

4. All options awarded in 12/19/1999 grant currently exercisable

5. All options awarded in 1/3/2001 grant currently exercisable

6. Vest equally over five years beginning 12/20/2003

7. Vest equally over three years beginning 01/14/2006

Remarks:

	/s/ Lynn Rogers, Attorney-in-fact	08/18/2005
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.